Kevin Pong

Kevin Pong

Company: Anima Biotech

Job title: Chief Business Officer


Translation Regulation of KRAS mRNA as a Unique Mutation Agnostic Approach 4:00 pm

Cancer biology: KRAS mRNA dysregulation as a driver for tumorigenesis Discovery platform: Screening for small molecules modulating mutant KRAS mRNA translation Anima’s KRAS mRNA translation modulators target the increased translation efficiency of mutant KRAS in tumor cellsRead more

day: Day Two Track E

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.